Vaccines, drugs, and modified human cells that activate the immune system against cancer have improved outcomes and prolonged lives in some types of cancer in the past few years. For patients with glioblastoma, the most common primary brain tumor in adults, immunotherapy has shown some promise in clinical trials — […]
There are many different pediatric brain tumor types and classifications based upon the tumor’s cell structure, composition, rate of growth, location, and other characteristics. A child’s tumor may have the same microscopic appearance to an adult tumor, but the mutations that cause its growth are completely different. Learn more […]
In most cases, the diagnosis of a brain tumor can’t be traced to a particular cause or risk factor. As with many forms of cancer, brain tumor risk increases with age – although tumors can develop in younger people – and men have a somewhat greater risk than women. About […]
The brain controls many vital bodily functions – and when a tumor grows into or presses on an area of the brain, it may stop that part of the brain from functioning normally. Nearly 80,000 new cases of primary brain tumors are expected to be diagnosed this year, according to […]
For many brain tumor patients, surgery is an important step in the treatment process. While recovering from brain surgery can be a difficult process, your care team will help support you through treatment and guide you through the recovery process. Once a patient is cleared by their care team for […]
With football season in full swing, concussions and their long- and short-term consequences promise to be in the news. While the harmful effects of repeated concussions, especially among teens and young adults, have been well documented, any links between concussions and brain cancer are less clear. Multiple studies have endeavored […]
Historically, brain tumors have been some of the most challenging types of cancers. A protective barrier around the brain—called the “blood-brain barrier”—can prevent cancer treatments from reaching the tumor. Recently, increased interest in immunotherapy has given new hope to getting through this barrier. “We know the immune system can get […]
Brain tumors are relatively rare for people of any age, but they can occur in both children and adults. In fact, tumors of the spinal cord and brain are the second most common types of cancer in children, after leukemia. But there are some key differences between brain tumors that […]
Brain cancer takes a variety of forms – and research to better understand and treat it is progressing on a variety of fronts. One area of focus is the tumor microenvironment the skein of tissues and blood vessels that feed and support a tumor. Researchers are exploring how newly formed […]
This post originally appeared on HealthHub, a blog from Brigham and Women’s Hospital. Interested in seeing images of his brain, Steven Keating, currently a graduate student at the MIT Media Lab, volunteered for a research study while attending school in Canada in 2007. When researchers returned his brain scans, they […]
Until a few years ago, there were only a handful of known survivors of atypical teratoid rhabdoid tumor (AT/RT), a rare cancer that affects the brain and central nervous system. When researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center studied how these few survivors were treated, they found three […]
The information used in diagnosing a brain tumor takes many forms. At Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), patients’ brain tumor tissue undergoes a broad range of diagnostic tests: not only standard pathology exams in which tumor cells are viewed under a microscope, but also next-generation scans for mutated genes […]
Researchers in Dana-Farber’s Center for Neuro-Oncology are now launching attacks on glioblastomas from a new angle – by turning the patient’s immune system against the cancer cells. Where targeted chemotherapy uses drugs to disable proteins that cancer cells need to grow, immunotherapy drugs stimulate the patient’s immune system to recognize and […]
Dana-Farber Cancer Institute recently partnered with CancerConnect and Lakshmi Nayak, MD, to answer questions about brain cancer. Nayak is a neuro-oncologist in the Center for Neuro-Oncology at Dana-Farber/Brigham and Women’s Cancer Center and an instructor in neurology at Harvard Medical School. Q: There seems to be some progress concerning treatment […]
Targeted therapies and immunotherapy are in a phase of discovery that is more promising than any preceding brain cancer research, according to the leaders of Dana-Farber's Center for Neuro-Oncology.
A growing arsenal of new drugs that unleash the body’s immune system against tumors has captured the cancer treatment spotlight.
Findings from clinical trials have increased survival rates significantly in the last several decades for children with germ cell tumors.
A common question about severe or persistent headaches is whether they can be caused by a serious underlying health problem, such as a brain tumor.
Brain tumors are graded on a scale of 1 to 4, based on how malignant, or cancerous, they are, in an effort to anticipate the tumor's likely growth rate. A grade of 1 is the least malignant, and is considered low-grade, while 4 is the most malignant and considered high-grade.
Susan Johnson was diagnosed with a rare, slow-growing brain tumor in 1992. More than 25 years later, Susan is living with cancer — thanks to the chemotherapy, radiation, surgery and clinical trials that have kept her tumor at bay.